Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study | BMC Pharmacology | Full Text
ASPIRE Study: SMV + PEG-IFN + RBV for genotype 1 experienced patients - ppt download
Case Study 1: Relapser to PEG IFN-Alfa + RBV (Slides With Transcript)
Raised Serum Transaminases during Treatment with Pegylated Interferon for Chronic Hepatitis C
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
EP1087778B1 - Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c - Google Patents
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study - ScienceDirect
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG- IFN-β-1a | Bioanalysis
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB - Journal of Hepatology
Que faisons nous ? — Centre International de Recherche en Infectiologie
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. - Abstract - Europe PMC
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study | PLOS ONE
Add-on, switch-to PEG-IFN therapy strategies improve serological response in CHB patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion | PLOS ONE
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/773a2ed1c92ed98831267442933ac3793394f2a7/4-Figure1-1.png "PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar")
PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar
